[RGLS] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
08-Aug-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- -30.31%
YoY- -57.36%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 0 0 0 0 0 18 18 -
PBT -11,035 -7,012 -7,258 -6,033 -6,947 -5,015 -13,847 -3.70%
Tax 1 1 83 1 10 1 118 -54.81%
NP -11,036 -7,013 -7,341 -6,034 -6,947 -5,016 -13,847 -3.70%
Tax Rate - - - - - - - -
Total Cost 11,036 7,013 7,341 6,034 6,947 5,034 13,865 -3.72%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -27,866.67 -76,927.78 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.17 -0.37 -0.50 -0.78 -2.33 -3.00 -15.93 -53.04%
EPS Diluted -0.17 -0.37 -0.50 -0.78 -2.33 -3.00 -15.93 -53.04%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.